141 related articles for article (PubMed ID: 7543053)
1. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
Yoshinaka Y; Katoh I; Kyushiki H; Sakamoto Y
Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053
[TBL] [Abstract][Full Text] [Related]
2. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
[TBL] [Abstract][Full Text] [Related]
4. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
Agbotounou WK; Levitzki A; Jacquemin-Sablon A; Pierre J
Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714
[TBL] [Abstract][Full Text] [Related]
5. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
Zhong H; Minneman KP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
[TBL] [Abstract][Full Text] [Related]
6. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
Buss JE; Chouvet C; Gill GN
J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
Mishra S; Mathur R; Hamburger AW
Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
[TBL] [Abstract][Full Text] [Related]
8. Application of two-dimensional gel analysis to identification and characterization of tyrosine phosphorylated substrates for growth factor receptors.
Hansen K; Møller JV
Electrophoresis; 1993; 14(1-2):112-26. PubMed ID: 7681772
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
10. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
Han Y; Caday CG; Nanda A; Cavenee WK; Huang HJ
Cancer Res; 1996 Sep; 56(17):3859-61. PubMed ID: 8752145
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation.
Chess PR; Ryan RM; Finkelstein JN
Pediatr Res; 1994 Oct; 36(4):481-6. PubMed ID: 7529394
[TBL] [Abstract][Full Text] [Related]
12. Actin polymerization localizes to the activated epidermal growth factor receptor in the plasma membrane, independent of the cytosolic free calcium transient.
Rijken PJ; Post SM; Hage WJ; van Bergen en Henegouwen PM; Verkleij AJ; Boonstra J
Exp Cell Res; 1995 May; 218(1):223-32. PubMed ID: 7737361
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.
Juang SH; Carvajal ME; Whitney M; Liu Y; Carraway CA
Oncogene; 1996 Mar; 12(5):1033-42. PubMed ID: 8649794
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.
Yoneda T; Lyall RM; Alsina MM; Persons PE; Spada AP; Levitzki A; Zilberstein A; Mundy GR
Cancer Res; 1991 Aug; 51(16):4430-5. PubMed ID: 1651159
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
Ahmad F; Goldstein BJ
J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
[TBL] [Abstract][Full Text] [Related]
19. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src.
Akiho H; Tokumitsu Y; Noda M; Nomura Y
Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
